Clinically significant fetomaternal hemorrhage, a rare condition in which fetal blood enters the mother’s blood circulation, can trigger fetal and neonatal alloimmune thrombocytopenia (FNAIT), underscoring the need for rapid recognition and intervention to protect both mother and infant, according to a case report published recently in Cureus.
In this case, a 40-year-old woman at 34 weeks and 3 days’ gestation presented with absent fetal movement for four to six hours after a day of reduced activity. Just two days earlier, imaging and blood flow studies were normal. On arrival, fetal monitoring showed concerning signs including tachycardia, low variability and decelerations, which progressed despite treatment. An emergency cesarean delivery was performed within 30 minutes.
The newborn was critically ill at birth, requiring four minutes of cardiopulmonary resuscitation followed by respiratory support. Initial testing revealed a hemoglobin of 20 g/L, far below the normal range of 120 to 225 g/L. The infant received two transfusions, raising hemoglobin to 100 g/L. Further testing confirmed a massive 134 mL fetomaternal hemorrhage.
This case demonstrated that even low-risk pregnancies with reassuring testing can deteriorate quickly, yet still result in good outcomes with timely care. Fetomaternal hemorrhage occurs in small amounts in most pregnancies that are affected. Severe cases, which are defined as more than 30 mL of fetal blood transfer, affect about three in 1,000 pregnancies and can lead to dangerous fetal anemia.
While FNAIT involves immune-mediated platelet destruction rather than blood loss, both conditions can cause serious neonatal complications and require urgent evaluation. Shared concerns include bleeding risk and the need to rule out overlapping causes of anemia or thrombocytopenia.
“The difficulty in identifying clear factors that explain the majority of FMH [fetal maternal hemorrhage] cases suggests a need for further research in this area and also increases the importance of accurate and timely diagnostic techniques for FMH,” the authors wrote.
Read more about FNAIT causes and risk factors
Although the mother had thrombocytopenia during pregnancy, it was consistent with gestational thrombocytopenia rather than FNAIT. This distinction mattered because FNAIT can increase bleeding complications in newborns, while this infant’s low platelets were likely due to consumption from severe illness. The baby ultimately recovered after neonatal intensive care, with a minor brain bleed that resolved before discharge.
For patients, this case may emphasize that decreased fetal movement should never be ignored, even after reassuring prenatal visits. It also shows that rare conditions like fetomaternal hemorrhage can arise suddenly without clear risk factors. Early evaluation, rapid delivery when needed and access to neonatal intensive care can significantly improve outcomes, offering reassurance that even severe disease can end in recovery.
Sign up here to get the latest news, perspectives, and information about FNAIT sent directly to your inbox. Registration is free and only takes a minute.
